Stablepoint Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Buy
33,442
+30
+0.1% +$1.34K 0.2% 134
2026
Q1
$1.61M Buy
33,412
+4,169
+14% +$194K 0.24% 122
2025
Q4
$1.42M Sell
29,243
-1,145
-4% -$56.8K 0.22% 124
2025
Q3
$1.43M Buy
30,388
+2,815
+10% +$136K 0.23% 126
2025
Q2
$1.33M Buy
27,573
+628
+2% +$32.1K 0.23% 132
2025
Q1
$1.49M Buy
26,945
+1,882
+8% +$102K 0.27% 110
2024
Q4
$1.21M Buy
25,063
+1,170
+5% +$59.5K 0.22% 128
2024
Q3
$1.38M Buy
23,893
+189
+0.8% +$10.2K 0.25% 115
2024
Q2
$1.23M Buy
23,704
+3,556
+18% +$172K 0.24% 124
2024
Q1
$979K Buy
20,148
+2,135
+12% +$104K 0.2% 135
2023
Q4
$896K Buy
+18,013
New +$881K 0.23% 121

Other funds holding SNY

Stablepoint Partners's SNY Position: Q2 2026 in Review

Stablepoint Partners increased its Sanofi (SNY) stake by 0.09% in Q2 2026, buying an estimated $1.34K and bringing the position to 33,442 shares worth $1.43M. The position accounts for 0.2% of the portfolio, ranked #134.

Stablepoint Partners first reported a position in SNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.61M in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Stablepoint Partners held 33,442 shares of Sanofi worth $1.43M as of Q2 2026.
  • Stablepoint Partners bought 30 Sanofi shares in Q2 2026, an estimated $1.34K.
  • Sanofi made up 0.2% of Stablepoint Partners's portfolio in Q2 2026, its #134 holding.
  • Stablepoint Partners first reported a position in Sanofi in Q4 2023 and has held it in 11 quarters since.
  • Stablepoint Partners's Sanofi position peaked at $1.61M in Q1 2026.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.